Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMFA04010030 ent-7-F4c-NeuroP (R,4Z,8E)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010027 ent-7-F4t-NeuroP (R,4Z,8E)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010470 ent-7-J4-NeuroP (R,4Z,8E)-7-hydroxy-9-((1R,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010436 ent-7-epi-14-A4-NeuroP (Z)-6-((1R,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010220 ent-7-epi-14-D4c-NeuroP (Z)-6-((1R,2R,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010221 ent-7-epi-14-D4t-NeuroP (Z)-6-((1S,2S,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010348 ent-7-epi-14-E4c-NeuroP (Z)-6-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010349 ent-7-epi-14-E4t-NeuroP (Z)-6-((1S,2S,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010092 ent-7-epi-14-F4c-NeuroP (Z)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010093 ent-7-epi-14-F4t-NeuroP (Z)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010500 ent-7-epi-14-J4-NeuroP (Z)-6-((1S,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010396 ent-7-epi-4-A4-NeuroP (R,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010140 ent-7-epi-4-D4c-NeuroP (R,E)-4-hydroxy-6-((1R,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010141 ent-7-epi-4-D4t-NeuroP (R,E)-4-hydroxy-6-((1S,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010268 ent-7-epi-4-E4c-NeuroP (R,E)-4-hydroxy-6-((1R,2R,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010269 ent-7-epi-4-E4t-NeuroP (R,E)-4-hydroxy-6-((1S,2S,3S)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010012 ent-7-epi-4-F4c-NeuroP (R,E)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010013 ent-7-epi-4-F4t-NeuroP (R,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010038 ent-7-epi-4-Fc-NeuroP (S,4Z,8E)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010035 ent-7-epi-4-Ft-NeuroP (S,4Z,8E)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010460 ent-7-epi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1S,5R)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010410 ent-7-epi-7-A4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010166 ent-7-epi-7-D4c-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010163 ent-7-epi-7-D4t-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010294 ent-7-epi-7-E4c-NeuroP (S,4Z,8E)-7-hydroxy-9-((1S,2R,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010291 ent-7-epi-7-E4t-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,2S,3S)-3-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopentyl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010474 ent-7-epi-7-J4-NeuroP (S,4Z,8E)-7-hydroxy-9-((1R,5R)-5-((2Z,5Z)-octa-2,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,8-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04020369 (10R,13R,16R)-d11-14-NeuroF[14R,17R] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2R,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020370 (10R,13R,16R)-d11-14-NeuroF[14R,17S] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2R,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020371 (10R,13R,16R)-d11-14-NeuroF[14S,17R] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020372 (10R,13R,16R)-d11-14-NeuroF[14S,17S] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2S,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020373 (10R,13R,16S)-d11-14-NeuroF[14R,17R] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2R,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020374 (10R,13R,16S)-d11-14-NeuroF[14R,17S] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2R,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020375 (10R,13R,16S)-d11-14-NeuroF[14S,17R] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2S,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020376 (10R,13R,16S)-d11-14-NeuroF[14S,17S] (4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-((2S,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020081 (10R,13R,17R)-d15-11-NeuroF[11R,14R] (R,4Z,7Z)-10-hydroxy-10-((2R,4R,5R)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020082 (10R,13R,17R)-d15-11-NeuroF[11R,14S] (R,4Z,7Z)-10-hydroxy-10-((2R,4R,5S)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020083 (10R,13R,17R)-d15-11-NeuroF[11S,14R] (R,4Z,7Z)-10-hydroxy-10-((2S,4R,5R)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020084 (10R,13R,17R)-d15-11-NeuroF[11S,14S] (R,4Z,7Z)-10-hydroxy-10-((2S,4R,5S)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020085 (10R,13R,17S)-d15-11-NeuroF[11R,14R] (R,4Z,7Z)-10-hydroxy-10-((2R,4R,5R)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020086 (10R,13R,17S)-d15-11-NeuroF[11R,14S] (R,4Z,7Z)-10-hydroxy-10-((2R,4R,5S)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020087 (10R,13R,17S)-d15-11-NeuroF[11S,14R] (R,4Z,7Z)-10-hydroxy-10-((2S,4R,5R)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020088 (10R,13R,17S)-d15-11-NeuroF[11S,14S] (R,4Z,7Z)-10-hydroxy-10-((2S,4R,5S)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020377 (10R,13S,16R)-d11-14-NeuroF[14R,17R] (4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2R,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020378 (10R,13S,16R)-d11-14-NeuroF[14R,17S] (4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2R,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020379 (10R,13S,16R)-d11-14-NeuroF[14S,17R] (4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020380 (10R,13S,16R)-d11-14-NeuroF[14S,17S] (4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2S,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020381 (10R,13S,16S)-d11-14-NeuroF[14R,17R] (4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2R,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020382 (10R,13S,16S)-d11-14-NeuroF[14R,17S] (4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2R,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6
LMFA04020383 (10R,13S,16S)-d11-14-NeuroF[14S,17R] (4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-((2S,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid Docosanoids [FA04] Neurofurans [FA0402] 394.24 C22H34O6